Kiniksa Pharmaceuticals International (KNSA) Non-cash Items (2017 - 2026)

Kiniksa Pharmaceuticals International has reported Non-cash Items for 10 years, with the latest figure at $6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items fell 20.94% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (down 20.94% YoY), and the FY2025 full-year result was $213.3 million, up 242.18% from the prior year.
• Non-cash Items for Q1 2026 stood at $6.1 million, down from $213.3 million in the prior quarter.
• The five-year high for Non-cash Items was $213.3 million in Q4 2025, with the low at $5.1 million in Q1 2022.
• Historically, Non-cash Items has averaged $26.4 million across 5 years, with a median of $7.2 million in 2025.
• Annual changes were most pronounced in 2025 — Non-cash Items jumped 242.18% — and 2026, when it fell 20.94%.
• Kiniksa Pharmaceuticals International's Non-cash Items stood at $32.6 million in 2022, then jumped by 67.47% to $54.7 million in 2023, then climbed by 14.05% to $62.3 million in 2024, then jumped by 242.18% to $213.3 million in 2025, then tumbled by 97.12% to $6.1 million in 2026.
• The last three Non-cash Items figures came in at $6.1 million (Q1 2026), $213.3 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.